Chinese english Germany Japanese Korea

leridistim

leridistim Struktur
193700-51-5
CAS-Nr.
193700-51-5
Englisch Name:
leridistim
Synonyma:
SC-70935;leridistim;14-125-Interleukin 3 (14-alanine) (human reduced) fusion protein with peptide (synthetic) fusion protein with granulocyte colony-stimulating factor (17-serine) (human reduced)
CBNumber:
CB71361309
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file
Request For Quotation

leridistim Eigenschaften

Sicherheit

leridistim Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Treatment of chemotherapy-in-duced neutropenia and thrombocytopenia (multifunctional agonist that activates both interleukin-3 and G-CSF receptors).

leridistim Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

leridistim Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Beijing HuaMeiHuLiBiological Chemical 010-56205725
waley188@sohu.com China 12338 58
Nanjing Leon Biological Technology Co., Ltd. 17705183659
 sales@njleonbiotech.com China 5503 55
Nanjing Peptide Biotech Ltd. 025-025-58361106-805-805 13082558573
 liugang@njpeptide.com China 9962 55
Nanjing Meihao Pharmaceutical Technology Co., Ltd. meitaochem@126.com
meitaochem@126.com China 19105 58
  • leridistim
  • SC-70935
  • 14-125-Interleukin 3 (14-alanine) (human reduced) fusion protein with peptide (synthetic) fusion protein with granulocyte colony-stimulating factor (17-serine) (human reduced)
  • 193700-51-5
Copyright 2019 © ChemicalBook. All rights reserved